Next Generation Market Consulting Services
Global Next Generation Sequencing (NGS) Market Report: Assessment, Trends, and Forecast (2022-2027)
This new report provides an in-depth analysis of the global NGS market including assessment, trends, competition, and forecasts for 2022–2027. The report estimates the value of the global NGS market in 2022 at $10.9 billion. The NGS market is expected to grow at a 15% CAGR over the forecast period, reaching $21.7 billion in 2027.
Key growth drivers include increased utilization of NGS solutions and the development of new applications such as the use of liquid biopsy testing for early cancer detection and non-invasive prenatal testing. Oncology and reproductive health testing are the largest clinical specialties involved in NGS market growth. North America represents the largest regional NGS market. Among manufacturers, one company currently dominates the global marketplace, but numerous market entrants are making significant inroads in both research and clinical segments.
With a growing demand for the clinical application of NGS testing, market access and reimbursement remain the greatest barriers to widespread adoption.
Welcome to The Deerbone Group, a leading boutique management consultancy known for its specialization in next generation sequencing strategy. boutique consultancyexpertise in next-generation sequencing.
The Importance of Next-Generation Sequencing Market Consulting Services
In today's fast-paced market, next-generation sequencing is more than just a technological advance; it's a game-changer. Companies that understand this technology can stay ahead of the competition, improve efficiencies, and make better-informed decisions.
That's where the team at The Deerborne Group steps in. With a broad range of next-generation sequencing market consulting services, we help you stay ahead of the curve and advance promising diagnostic solutions so that you can move toward the next chapter of your business.
Explore Our Wide Range of Consulting Services
At The Deerbone Group, we offer a range of NGS market consulting services and support designed to meet the diverse needs of our clients in this dynamic market.
Regulatory Strategy and Support
The Deerborne Group offers our clients comprehensive scientific and clinical expertise to support a wide array of FDA regulatory submissions. Whether it's analytical and clinical validations or navigating through a 510K, De Novo, or even a full PMA, we are dedicated to supporting all facets of your product development efforts.
Clinical Trial Design and Strategy
A well-crafted clinical trial design stands as a cornerstone for a thriving clinical trial program, ensuring precision, safety, and timely execution across all study sites. Tailored strategies adeptly integrate scientific, regulatory, and commercial considerations unique to each trial, thereby minimizing risk and propelling the advancement of innovative diagnostic solutions.
At The Deerborne Group, we specialize in providing an extensive array of next-generation sequencing consulting services. Backed by our comprehensive portfolio, our clients gain access to the essential tools and insights required to maintain competitiveness and propel their business endeavours. Rely on The Deerborne Group to navigate your business through the intricate landscape of the global next-generation sequencing market.